Background A major debate in the quality-adjusted life-year (QALY) literature concerns
whose preferences should be used to estimate health state values (HSVs) and to calculate …

Objective In economic evaluation, health outcomes are commonly quantified using quality-
adjusted life-years (QALYs) derived from the preferences of a sample of the general …

Background Condition-specific measures are frequently used to assess the health-related
quality of life of people with multiple sclerosis (MS). Such measures are unsuitable for use in …

Background Increasingly, generic preference-based measures of health-related quality of
life (HRQOL) are used to estimate quality-adjusted life-years to inform resource allocation …

abstract Objectives To estimate health state utility values (HSUVs) for multiple sclerosis (MS)
by key demographic and clinical characteristics. Methods Data from a UK prospective …

Background: The measurement of health state utility values (HSUVs) for a representative
sample of Australian people with multiple sclerosis (MS) has not previously been performed …

Cost-effectiveness analyses using quality-adjusted life-years (QALYs) are used in decision-
making regarding which interventions are available via many national healthcare systems …

Background New interventions for multiple sclerosis (MS) commonly require a
demonstration of cost-effectiveness using health-related quality of life (HRQoL) utility values …

Abstract Objectives The 29-item Multiple Sclerosis Impact Scale (MSIS-29) is a
psychometrically validated patient-reported outcome measure increasingly used in trials of …

Objective: To examine preferences for treatments and health states for patients with
relapsing-remitting MS and members of the community. Methods: A survey was developed …